Navigation Links
Sanofi-aventis Announces Second Quarter 2009 Results
Date:7/29/2009

BRIDGEWATER, N.J., July 29 /PRNewswire-FirstCall/ --

                                      Change                      Change
                           Change       at              Change      at
                            on a     constant            on a    constant
                   Q2     reported   exchange          reported  exchange
                  2009     basis      rates    H1 2009   basis     rates
                 -------  ---------  --------  -------  -------   -------
    Net           euro                           euro
     sales       7,438m     +11.2%      +6.5%  14,545m    +6.7%     +3.1%
    Adjusted
     net
     income
     excluding
     selected     euro                           euro
     items       2,268m     +29.4%     +17.2%   4,446m   +22.3%    +12.8%
    Adjusted
     EPS
     excluding
     selected     euro                           euro
     items        1.74      +29.9%     +17.2%    3.41    +23.1%    +13.4%

In order to facilitate an understanding of our operational performance, we comment on our adjusted income statement excluding selected items, a non-GAAP financial measure. The 2009 first-half consolidated income statement is provided in Appendix 5, as are details of adjustments and selected items. Consolidated net income for the first half of 2009 was euro 2,637 million, versus euro 2,335 million for the first half of 2008. Consolidated earnings per share for the first half of 2009 was euro 2.02, against euro 1.78 for the first half of 2008.

Good performance(1) in the second quarter of 2009

  • Strong growth from Lantus(R) (up 26.0%), Lovenox(R) (up 13.3%) and Taxotere(R) (up 10.7%). Further dynamism in the worldwide presence of Plavix(R) (up 9.6%)

  • Growth of 18.4% for the Vaccin
    '/>"/>

SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27

Related biology technology :

1. Sanofi-aventis Announces Settlement of Average Wholesale Price Civil Suits With the U.S. Department of Justice Relating to Anzemet(R)
2. Shareholder Class Action Filed Against Sanofi-Aventis by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
3. Sanofi-aventis SoloSTAR(R) Insulin Pen for Lantus and Apidra Receives the Prestigious GOOD DESIGN Award
4. ThalesNano Inc. and sanofi-aventis R&D Collaborate on Continuous Process Chemistry in Order to Dramatically Reduce Drug Realization Time
5. RainDance Technologies Signs a Collaboration Agreement with sanofi-aventis and Louis Pasteur University to Launch dScreen Consortium within ALSACE BIOVALLEY cluster
6. AEterna Zentaris and Sanofi-Aventis Sign a Development, Commercialization and Licensing Agreement for Cetrorelix in Benign Prostatic Hyperplasia
7. BioWa Announces License of POTELLIGENT(R) Technology to sanofi-aventis
8. Sanofi-aventis U.S. to Acquire Oral Chronic Lymphocytic Leukemia Treatment
9. Sanofi-aventis U.S. Announces Settlement of Medicaid Best Price Investigation
10. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
11. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
(Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
... SAN FRANCISCO, March 16 Medivation, Inc. (Nasdaq: ... and financial results for the fourth quarter and year ended December ... to an equally exciting 2009. We have made excellent progress across ... testing in all of our programs in 2009 -- Dimebon in ...
... 16 TauTaTis, Inc. announces that its lead compound ... process in Alzheimer,s Disease, has been recognized as the ... Disease gene LRRK2 reported to date. Mutations of ... are the most genetic frequent cause of Parkinson,s Disease.TauTaTis, ...
... Provider, Offers Traceability Down to the Unit Level to Secure ... ... Southborough, MA (PRWEB) March 16, 2009 -- PHARMORX ... technology services provider, today announced the availability of its new ...
Cached Biology Technology:Medivation Reports Fourth Quarter and Year-End 2008 Financial Results and Provides Corporate Update 2Medivation Reports Fourth Quarter and Year-End 2008 Financial Results and Provides Corporate Update 3Medivation Reports Fourth Quarter and Year-End 2008 Financial Results and Provides Corporate Update 4Medivation Reports Fourth Quarter and Year-End 2008 Financial Results and Provides Corporate Update 5Medivation Reports Fourth Quarter and Year-End 2008 Financial Results and Provides Corporate Update 6Medivation Reports Fourth Quarter and Year-End 2008 Financial Results and Provides Corporate Update 7Medivation Reports Fourth Quarter and Year-End 2008 Financial Results and Provides Corporate Update 8TauTaTis Discovers Potent Inhibitor of Parkinson's Disease Gene Activity 2PHARMORX Security Introduces New Technology Solutions for Counterfeiting, Grey Market Diversion, Track & Trace 2PHARMORX Security Introduces New Technology Solutions for Counterfeiting, Grey Market Diversion, Track & Trace 3
(Date:4/15/2014)... CLEVELAND, Ohio (April 16, 2014)A new study from the ... vitamin D levels and menopause symptoms. The study was ... of The North American Menopause Society., The authors analyzed ... and a number of menopause symptoms, including hot flashes, ... women who participated in the calcium and vitamin D ...
(Date:4/15/2014)... in Greenbelt, Md., is home to hundreds of ... Goddard, some of the most cutting-edge Earth science ... that cutting-edge innovation has earned a Goddard scientist ... for Anthropology and Geography awards the Vega Medal ... shown excellence in the fields of physical geography, ...
(Date:4/15/2014)... Missouri researchers have previously shown that a genetic pre-disposition ... In a new study, Frank Booth, a professor in ... potential link between the genetic pre-disposition for high levels ... maturation occurs. , For his study, Booth selectively bred ... extreme laziness. Booth then put the rats in cages ...
Breaking Biology News(10 mins):Low Vitamin D may not be a culprit in menopause symptoms 2Goddard scientist receives Vega Medal from King of Sweden 2Genetic pre-disposition toward exercise and mental development may be linked 2
... dreaded disease in medieval Europe ?to fade from the ... disappeared there. , The reason seems to be, say ... London, that tuberculosis, a far more deadly disease, overtook ... based upon the examination of DNA from human remains ...
... Throughout the animal kingdom, rival males routinely challenge one ... collisions between bighorn rams to the ritualized wrestling matches ... reproductive success. , But now scientists studying a ... male cichlids can quickly become leading men without even ...
... provide some protection to the heart from injury even ... heart attack, Jefferson Medical College researchers report. , Walter ... in the Department of Medicine at Jefferson Medical College ... knew that the drug Darbepoietin alpha would protect the ...
Cached Biology News:Once-dreaded leprosy 'replaced' by tuberculosis, say researchers 2Sudden change in social status triggers genetic response in male fish, study finds 2Sudden change in social status triggers genetic response in male fish, study finds 3Sudden change in social status triggers genetic response in male fish, study finds 4Sudden change in social status triggers genetic response in male fish, study finds 5Sudden change in social status triggers genetic response in male fish, study finds 6
... end-users to be "a delight to use" ... microscopy and electronic imaging. With its ergonomic ... require much space and can easily be ... DM-BA300 combines Motic's own revolutionary Colour Corrected ...
Request Info...
When added to StemSep T Cell Enrichment cocktail, human TCRab TAC is designed to deplete human TCRab from samples to isolate gd T cells....
When added to either StemSep CD4+ or CD8+ T Cell Enrichment cocktails, human CD69 TAC is designed to deplete human CD69 from samples to isolate resting CD4+ or CD8+ T cells....
Biology Products: